Cannabis Law Report

JULY 19, 2019

FWB: 8K51)(OTC: WLDCF) (the “Company” or “ ICC ” or “ International Cannabis”) is pleased to announce that the Company has entered into an exclusive supply and commercial rights agreement (the “Agreement”) with licensed New Zealand medical cannabis company, NUBU Pharmaceuticals (“NUBU”). (CSE: WRLD.U)(FWB:

Pharmaceutical 40

Pharmaceutical THC CBD Supply Chain 40

Cannabis Law Report

SEPTEMBER 14, 2021

Join Us in Advancing Cannabis Science to Elevate the Industry , by Pelin Thorogood, Co-founder and Executive Chair of Radicle Science, and Nicole Brown, Chief Innovation Officer of Open Book Extracts. About Open Book Extracts. About Radicle Science. To learn more, please visit www.radiclescience.com and follow their LinkedIn page.

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

Veriheal

AUGUST 9, 2023

This new research has increased our hopes for an alternate CBD source, which may increase the availability of CBD-based products, reduce purchase costs, and guarantee THC-free extracts. Even more, CBD is the first FDA-approved pharmaceutical drug for two rare forms of epileptic seizures in kids.

CBD 96

CBD Cannabinoids THC Extraction 96

Cannabis Law Report

JULY 7, 2022

In December 2020, Canopy Growth Corporation (“Canopy”) filed a complaint for patent infringement against GW Pharmaceuticals PLC (“GW”) in the United States District Court for the Western District of Texas. Patent 2 which relates to a process of extracting CBD using carbon dioxide.

Pharmaceutical 52

Pharmaceutical Extraction Conditions CBD 52

Cannabis Law Report

JANUARY 16, 2022

Malaysia’s National Pharmaceutical Regulatory Agency (NPRA) previously approved a prescription medicine derived from cannabis in 2014 to treat muscle spasms and spasticity from multiple sclerosis. Sativex was developed by GW Pharmaceuticals, a maker of cannabinoid therapeutics based in Ireland.

Pharmaceutical 98

Pharmaceutical Research and Development Epilepsy Medicine 98

MMJ Recs

JULY 11, 2024

Medical marijuana is a potential treatment for insomnia, and it offers an alternative to traditional pharmaceuticals. It can be caused by a variety of factors, including medical conditions, psychological issues, or environmental factors. It can be caused by underlying health conditions, medications, or psychological factors.

Sleep 111

Sleep Treatment Research and Development Therapy 111

United Patients Group

APRIL 18, 2023

Because they often combine it with other drugs like cocaine or heroin or even legal ‘prescribed’ pharmaceuticals–and those are far more dangerous than cannabis itself! Another example, Age, weight, current health condition, sensitivities and even drug to drug interactions should be addressed.

Research and Development 116

Research and Development Indica Treatment Conditions 116

The Cannigma

FEBRUARY 1, 2023

Individuals who use cannabis-based medications often want to cure their cancer, not just reduce the symptoms that come with the condition. Work together to weigh the potential benefits and risks specific to your medical condition, and track the progress of your cancer along with your cannabis regimen. 1 So can cannabis cure cancer?

Clinical Trials 145

Clinical Trials Research and Development Therapy Cannabinoids 145

TheAnswerPage

MAY 20, 2022

Has any national drug administration approved a CBD-containing product for therapeutic use in conditions other than epilepsy? GW Pharmaceuticals website. See the Answer.

Nerve Pain 52

Nerve Pain Epilepsy Pharmaceutical Cannabinoids 52

Project CBD

MARCH 8, 2019

For years, hemp companies have been producing CBD rich extracts and marketing them for animals and humans. Immediately in response, the FDA announced that CBD is considered a “drug” and is thus subject to pharmaceutical regulations. Hemp is defined as cannabis that naturally produces less than 0.3%

Pets 215

Pets Legalization Hemp Extraction 215

Cannabis Law Report

JUNE 28, 2021

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. Zambon is a multinational pharmaceutical company that focuses on innovation and development with the aim to improve patients’ lives. The market for medical cannabis in Germany.

Access 105

Access Research and Development Pharmaceutical Therapy 105

Veriheal

MARCH 7, 2023

Beis expressed his excitement about the factory being the largest pharmaceutical facility in Europe, where a medical cannabis industry is sprouting across Luxembourg, Germany, and Malta. “A M edicinal-grade cannabis will be cultivated inside a 25,000-square-foot extraction and processing facility as part of the Greek Kaya Project.

Marijuana 98

Marijuana Pharmaceutical Medicine Cultivation 98

MMJ Recs

APRIL 1, 2024

CBD, one of the many cannabinoids found in the cannabis plant, has been garnering attention for its promising effects on various health conditions. From its anti-inflammatory properties to its ability to alleviate pain, CBD shows promise in addressing various health conditions.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

Cannabis Law Report

AUGUST 12, 2021

Since 2013, medicinal cannabis has been legalized in the Czech Republic due to the amendment to the Act on pharmaceuticals, otherwise known as Act No. With medical research indicating that using the plant provides significant medical benefits, the Czech Chamber of Deputies suggested a revision to the government’s Act on pharmaceuticals.

Legalization 59

Legalization Pharmaceutical Safety Extraction 59

TheAnswerPage

AUGUST 19, 2021

Has any national drug administration approved a CBD-containing product for therapeutic use in conditions other than epilepsy? GW Pharmaceuticals website. See the Answer.

Nerve Pain 52

Nerve Pain Epilepsy Pharmaceutical Cannabinoids 52

Canna Care Docs

OCTOBER 3, 2023

However, many of these pharmaceutical medications can just induce more unpleasant, debilitating effects on those who are ill. Depending on the type of terminal illness diagnosed by the doctor, there are numerous pharmaceutical and conventional medications provided for patients to treat the symptoms that come with a terminal illness.

Chronic Pain 105

Chronic Pain Clinical Trials Patients Cannabinoids 105

Cannabis Law Report

JANUARY 14, 2022

Unapproved medications such as cannabis in Germany can only be approved on the basis of three criteria: (1) When it is for the treatment of a serious (life-threatening or permanently detrimental to the quality of life) medical condition; (2) Where no other therapy is available; and. (3) Canopy sold the company for a maximum of €122.6

Pharmaceutical 52

Pharmaceutical Extraction Oil Patients 52

TheAnswerPage

JUNE 14, 2021

Has any national drug administration approved a CBD-containing product for therapeutic use in conditions other than epilepsy? ” GW Pharmaceuticals website. See the Answer.

Nerve Pain 52

Nerve Pain Epilepsy Pharmaceutical Cannabinoids 52

Cannabis Law Report

AUGUST 6, 2021

When you’re buying CBD to treat your seizures, you need to make sure that you buy pure CBD extract. A lot of people are not comfortable with taking pharmaceutical medication. CBD can be a great way to treat your pain without taking pharmaceutical medication. Don’t swap out pharmaceutical medication for CBD treatment completely.

CBD 105

CBD Wellness and Beauty Treatment Pharmaceutical 105

Canna Care Docs

SEPTEMBER 18, 2020

To prepare for your appointment you will want to collect your medical records about the condition you wish to treat with medical cannabis. This can be as simple as taking a picture of a prescription bottle you have been given to treat your condition. What Conditions Qualify for Medical Marijuana Cards in Virginia?

Pharmaceutical 98

Pharmaceutical Conditions Patients Oil 98

United Patients Group

FEBRUARY 7, 2023

Inflammation can lead to a wide range of diseases and conditions, including heart disease, arthritis and cancer. This article will cover some common uses for medical cannabis when treating inflammation or pain along with what other ingredients might be helpful in reducing symptoms related to these conditions!

Cannabinoids 116

Cannabinoids Chronic Pain Terpenes THC 116

Cannabis Law Report

OCTOBER 6, 2021

The CBD oil shipped will be used as the primary ingredient for compounding formulations that Futura Farms is distributing to pharmaceutical establishments that have fulfilled their Good Storage Practices (“ GSP ”) requirements issued by Peru’s General Directorate of Medicines, Supplies and Drugs (“ DIGEMID ”).

Oil 52

Oil CBD Conditions Pharmaceutical 52

Cannabis Law Report

OCTOBER 26, 2021

Following this selection, Tilray will supply a variety of its pharmaceutical-grade medical cannabis products, including extracts and dried flower with different degrees of THC and CBD for patients with varying medical conditions.

Pharmaceutical 52

Pharmaceutical Research and Development Patients Access 52

Cannabis Law Report

MARCH 25, 2020

Panaxia Israel has just imported from the US hemp extracts from which it will manufacture CBD-rich cannabis products. Essence extraction was conducted in a facility jointly operated by Panaxia and Ultra Health located in New Mexico , US. About Panaxia Israel. and constitutes the Group’s cannabis division.

Oil 45

Oil Pharmaceutical Epilepsy Extraction 45

Cannabis Law Report

AUGUST 3, 2021

CSE: MXT) (OTCQB: MXTTF) is known for its award-winning extraction equipment, but recently, the company refocused its efforts on its proprietary health-related databases, machine learning analysis, and plans to engage in B2B licensing and mHealth. Medxtractor Corp. Mental health disorders are notoriously difficult to diagnose and treat.

Research and Development 105

Research and Development Data Conditions Therapy 105

SpeedWeed

AUGUST 1, 2021

announced on July 30 that the company’s CW Labs science division and Colorado State University’s (CSU) College of Agricultural Sciences have completed the first of three collaborative metabolomic hemp studies to decode the complex chemical profile of full spectrum hemp extracts—made from the company’s patented hemp cultivars. .

Hemp 52

Hemp Extraction Agriculture Strains 52

Cannabis Law Report

FEBRUARY 2, 2022

Lab Society is a Leader in Distillation and Solvent Separation Solutions for the Cannabis Extraction Industry with $10 Million in Annual Revenue. Acquisition Further Solidifies Agrify as the Largest and Most Comprehensive Provider of High- Quality Extraction Solutions for the Cannabis and Hemp Industry Globally. BILLERICA, Mass.,

Extraction 52

Extraction Pharmaceutical Hemp Cultivation 52

Cannabis Law Report

JUNE 19, 2022

Unlike novel chemical compounds that are synthetically produced in the pharmaceutical industry through drug development programs, psychedelic compounds have a long and established history. But evaluating the promise, and the risk, of a psychedelics IP portfolio is still mired in unknowns.

Clinical Trials 52

Clinical Trials Microdosing Data Pharmaceutical 52

Cannabis Law Report

JUNE 29, 2022

With the interest in potential utility of cannabis to develop treatments for a variety of medical conditions and the continued issuance of cannabis patents, the number of cannabis patent proceedings is likely to increase as well. Patent 1 , which claims various liquid formulations of enriched extracts of plant cannabinoids.

Research and Development 52

Research and Development Extraction Pharmaceutical Hemp 52

FloridaMarijuana.net

OCTOBER 5, 2018

In particular, terpenoids are contained in many herbal plants, and several terpenoids have been shown to be available for pharmaceutical applications. Phytol is considered a diterpene , present in cannabis extracts, as a breakdown product of chlorophyll and tocopherol. The post Terpene Spotlight: Phytol appeared first on.

Terpenes 181

Terpenes Strains Oil Medicine 181

Cannabis Law Report

OCTOBER 15, 2021

Last year, PAOG acquired intellectual property derived through research into CBD extracted in association with a patented extraction method (U.S. The ongoing research targets the treatment of respiratory disorders in support of a pharmaceutical being developed by PAOG under the name RespRx. 9,199,960).

Treatment 52

Treatment Research and Development CBD eCommerce 52

Cannabis Law Report

JUNE 28, 2021

Cannabis products are fast becoming available that could deliver significant improvements to the lives of thousands of patients suffering from conditions ranging from chronic pain to post traumatic stress disorder. It develops high-quality medical cannabis extract formulas, medical device vaporisers, and other innovative delivery methods.

Research and Development 105

Research and Development Chronic Pain Medicine Policy 105

The Blunt Truth

APRIL 20, 2021

The term does not include industrial hemp, as defined in state law, that is grown, dealt, or processed in compliance with state or federal law, unless it has been acquired and formulated with cannabis plant extract by a pharmaceutical processor.

Recreational 77

Recreational Legalization Oil Extraction 77

Miss Marijuana

NOVEMBER 4, 2020

As a company that takes pride in their safety level, Matter produces quality, effective, and consistent products that can provide therapeutic relief to those suffering from chronic medical conditions. The brand’s growers are pharmaceutical experts who think of the user’s best needs every step of the way. Abx – AbsoluteXrracts.

Strains 98

Strains Concentrates Extraction Pharmaceutical 98

The Cannigma

JUNE 15, 2021

More and more CBD products on the market promise relief from pain, depression, anxiety, neurodegenerative conditions, and a plethora of other symptoms and conditions. Benzodiazepines are often prescribed for conditions such as anxiety, insomnia, seizure control, and muscle relaxation. Easy access.

CBD 122

CBD Research and Development Epilepsy Extraction 122

The Cannigma

MARCH 7, 2022

Therefore, it makes sense that CBN is most commonly found in aged or improperly stored cannabis, and hardly ever present in fresh flower or low-temp extractions. Preclinical studies by InMed Pharmaceuticals showed that CBN not only reduced markers of inflammation and pain, but also increased keratin.

THC 140

THC Sleep Clinical Trials Cannabinoids 140

MJ Business Attorneys

JUNE 29, 2018

The FDA approved Epidiolex as a prescription drug to be used to treat two severe epileptic conditions, Lennox-Gastaut syndrome and Dravet syndrome. Even though the use of CBD for medicine has the support of the FDA, the methods of extracting CBD and the marketing of CBD products will likely become the subjects of high scrutiny.

DEA 113

DEA CBD Pharmaceutical Research and Development 113